Standout Papers

Overall Survival with Palbociclib and Fu... 2016 2026 2019 2022 773
  1. Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study (2022)
    Massimo Cristofanilli, Hope S. Rugo et al. Clinical Cancer Research
  2. Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer (2016)
    Charlotte Fribbens, Ben O’Leary et al. Journal of Clinical Oncology
  3. Treating cancer with selective CDK4/6 inhibitors (2016)
    Ben O’Leary, Richard S. Finn et al. Nature Reviews Clinical Oncology
  4. The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial (2018)
    Ben O’Leary, Rosalind Cutts et al. Cancer Discovery

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 58 standout
Sub-graph 1 of 19

Citing Papers

A pan-cancer analysis of the microbiome in metastatic cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
1 intermediate paper

Works of Ben O’Leary being referenced

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
2018
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
2016 Standout

Author Peers

Author Last Decade Papers Cites
Ben O’Leary 1614 1613 1263 36 2.6k
Rosalind Cutts 1416 1362 1536 29 2.5k
Tetiana Taran 1784 1682 994 29 2.7k
Gábor Rubovszky 1303 1163 1073 42 2.5k
Eva Ciruelos 1427 1338 912 76 2.4k
Janice M. Walshe 2422 2041 1119 69 3.3k
C. Giorgetti 2077 2144 874 33 2.9k
Katarína Petráková 2074 1351 962 64 2.7k
Paula Marrano 1922 2208 834 60 3.9k
Luca Malorni 1457 1033 845 77 2.2k
Ke Zhang 2445 3688 1280 30 4.3k

All Works

Loading papers...

Rankless by CCL
2026